Los Angeles, United States
Essenvia, founded in 2018, is reshaping the MedTech landscape with its MedTech RIM Platform, aimed at optimizing regulatory workflows throughout a product's entire lifecycle. The platform facilitates accelerated global market access and provides substantial business value.
Operating out of the United States, Essenvia lies at the intersection of Health Care, Information Technology, Medical Devices, and SaaS industries. Its ability to streamline regulatory processes makes it a pivotal asset for MedTech companies seeking to navigate complex regulatory environments effectively.
In its recent $4.00M Seed Round investment closed on 02 May 2023, Essenvia attracted significant interest from prominent investors, including Pasadena Angels, Rebright Partners, Benhamou Global Ventures, First Rays Venture Partners, and Wavemaker 360. This substantial backing underscores the robust confidence these investors have in Essenvia's innovative solution and future growth potential.
